Huntington disease: DNA analysis in Brazilian population

Arquivos de Neuro-Psiquiatria

Volumn 58, Issue 4, 2000, Pages 977-985

  Raskin, Salmo ^a,b   Allan, Nasser ^a   Teive, Hélio A G ^a   Cardoso, Francisco ^a   Haddad, Mônica Santoro ^a   Levi, Gilberto ^a   Boy, Raquel ^a   Lerena Jr , Juan ^a   Sotomaior, Vanessa Santos ^a   Janzen Dück, Mônica ^a   Jardim, Laura Bannach ^a   Fellander, Flávio R ^a   Andrade, Luiz Augusto Franco ^a  

^a Laboratory Genetika   (Brazil)

^b NONE   (Brazil)

Author keywords

Brazil; CAG repeats; DNA; Huntington disease; PCR

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CASE CONTROL STUDY; CHILD; ETHNOLOGY; FEMALE; GENETICS; GENOTYPE; HUMAN; HUNTINGTON CHOREA; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; ONSET AGE; POLYMERASE CHAIN REACTION; TRINUCLEOTIDE REPEAT;

ADOLESCENT; ADULT; AGE OF ONSET; BRAZIL; CASE-CONTROL STUDIES; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 0034576049     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2000000600001     Document Type: Article

References (29)

1. Hayden MR. Huntington's chorea. London: Springer, 1981:59-75.
2. Harper PS. Huntington's disease. Major problems in neurology Vol. 22. London: WB Saunders, 1991:31-72.
3. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded an unstable on huntington's disease chromosomes. Cell 1993;72:971-983.
4. Lin B, Rommens JM, Graham RK, et al. Differential 3′ polyadenylation of the Huntington disease gene results in two mRNA species with variable tissue expression. Hum Mol Genet 1993;2:1541-1545.
5. Pizzuti A, Friedman D, Caskey T. The myotonic dystrophy gene. Arch Neurol 1993;50:1173-1179.
6. Nagafuchi S, Yanagisawa H, Ohsaki E, Shirayama T, Tadokoro K. Structure and expression of the gene responsible for the triplet repeat disorder dentatorubral and pallidoluysian atrophy (DRPLA). Nat Genet 1994;8:177-182.
7. Orr H, Chung M, Banfi S, et al. Expansion of an unstable trinucleotide CAG-repeat in spinocerebellar ataxia type 1. Nat Genet 1993;4:221-226.
8. Kaimen-Maciel DR, Medeiros M, Climaco V, et al. Recessive bulbospinal muscular atrophy X-linked. Arq Neuropsiquiatr 1998;56:639-645.
9. LaSpada AR, Paulson H, Fishbeck K. Trinucleotide repeat expansion in neurological disease. Ann Neurol 1994;36:814-822.
10. American College of Medical Genetics/American Society of Human Genetics/Huntington Disease Genetic Testing Working Group (ACMG/ASHG Statement). Laboratory guidelines for Huntington disease genetic testing. Am J Hum Genet 1998;62:1243-1247.
11. McNeil SM, Novelletto A, Srinidhi J, et al. Reduced penetrance of the Huntington's disease mutation. Hum Mol Genet 1997;6:775-779.
12. Andrew SE, Goldberg YP, Theilmann J, Zeisler J, Hayden MR. A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington's disease gene: implications for diagnostic accuracy and predictive testing. Hum Mol Genet 1994;3:65-67.
13. Menkes JH. Huntington disease: finding the gene and after. Pediatr Neurol 1988;4:73-78.
14. Myers RH, Sax DS, Schoenfeld M, et al. Late onset of Huntington's Disease. J. Neurol. Neurosung Psychiatry 1985;48:530-534.
15. n changes in Huntington's disease. Mum Mol Genet 1995;4:189-195.
16. Kanazawa I. Prevalence rate of Huntington's chorea in Ibaraki prefectre. Ministry of Health and Welfare of Japan. 1983:151-156.
17. Hayden MR, MacGregor JM, Beighton PH. The prevalence of Huntington's chorea in South Africa. S Afr Med J 1980;58:193-196.
18. Wright HH, Still CN, Abramson RK. Huntington's disease in black kindreds in South Carolina. Arch Neurol 1981;38:412-414.
19. Squitieri F, Andrew SE, Goldberg YP, et al. DNA haplotype analyses of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence. Hum Mol Genet 1994;3:2103-2114.
20. Almqvist E, Spence N, Nichol K, et al. Ancestral differences in the distribution of the Δ2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease. Hum Mol Genet 1995;4:207-214.
21. John SWM, Weitzner G, Rozen R, Scriver CR. A rapid procedure for extracting genomic DNA from leukocytes. Nucleic Acids Res 1990;19:408.
22. Warner JP, Barron LH and Brock DJH. A new polymerase chain reaction (PCR) assay for the trinucleotide repeat that is unstable and expanded on Huntington's disease chromosomes. Mol. Cellular Probes 1993;7:235-239.
23. n repeats causing Huntington disease. Clin Chem 1996;42:1601-1603.
24. Goldberg YP, McMurray CT, Zeisler J, et al. Increase instability of intermediate alleles in families with sporadic Huntington disease compared to similar sized intermediate alleles in the general population Hum Mol Genet 1995;4:1911-1918.
25. Kremer HPH, Goldberg YP, Andrew SE, et al. A worldwide study of the Huntington's disease mutation: the sensitivity and specificity of measuring CAG repeats. N. Engl J Med 1994;330:1401-1406.
26. Brinkman RR, Mezei MM, Theilmann J, Almqvist E, Hayden MR. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am. J Hum Genet 1997;60:1202-1210.
27. Tzagournissakis M, Fesdjian CO, Shashidharan P and Plaitakis A. Stability of the Huntington disease (CAG)n repeat in a late-onset form occurring on the Island of Creta. Hum Mol Genet 1995;4:2239-2243.
28. Schumm JW, Lins AM, Micka KA, et al. Automated fluorescent detection of STR multiplexes. Proceedings from the first European Symposium on Human Identification 1996:90-104.
29. Almqvist EW, Bloch M, Brinkman R, Craufurd D, Hayden MR. A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Genet 1999;64:1293-1304.